McKesson Corporation (FRA:MCK)

Market Cap	84.33B
Revenue (ttm)	321.52B
Net Income (ttm)	2.69B
Shares Out	n/a
EPS (ttm)	21.25
PE Ratio	31.30
Forward PE	20.00
Dividend	2.68 (0.40%)
Ex-Dividend Date	Sep 2, 2025

Volume	13
Average Volume	42
Open	657.80
Previous Close	681.80
Day's Range	657.40 - 667.20
52-Week Range	457.00 - 681.80
Beta	n/a
RSI	65.05
Earnings Date	Nov 5, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD